6Th Annual Biopartnering North America Chika Hashimoto Gallasus, Inc
6th Annual BioPartnering North America Feb ruary 6 , 2008 | VBCCdVancouver, BC, Canada
Chika Hashimoto Gallasus, Inc.
Gallasus Drug Maker Devel Sales, Partner in U.S. oped $MN 2004 Drugs originated from Japan; Prevacid Takeda 1991 4,300 Novartis Pravachol Sankyo 1989 3,865 BMS Number of drugs,g >$500MN worldwide sales in 2004= 21 Levaquin Daiichi 1993 2,525 Ortho McNeil (166 drugs, total worldwide) Blopress Takeda 1997 2,136 Flomax Astellas 1993 2,111 Boehringer IlhiIngelheim Percentage of sales among Lupron Depot Takeda 1984 1,903 Abbott drugs sales >$500MN =13.3% Pariet Eisai 1997 1,845 Janssen Cilag Aricept Eisai 1999 1,717 Pfizer Actos Takeda 1999 1,703 Eli Lilly Biaxin®;Klacid Taisho 1990 1,240 Abbott Prograf Astellas 1993 1,085 Camptosar Yakuruto 1994 1,055 Pfizer Abilify OkOtsuka 2002 829 BMS Reference; Japan Pharmaceutical Manufactures Association Crestor Shionogi 2003 825 AstraZeneca Gallasus PtP%ercent 8 7 6 5 1998 4 1999 3 1998 and 1999 2 1 0 United States European Japan UiUnion
Source: organization for Economic Co-operation and Development, patent database (September 2004) Science and Engineering Indicators 2006
Gallasus 800
700 Japan
600
500
bers 400 mm Germany United Nu 300 Kingdom
200 Canada Netherlands 100 France
0 19931993 2003 2003
Source: U.S. Patent and Trademark Office, Office of Electronic Information Products, Patent TechnologyGallasus Monitoring Division, special tabulations (2004) Technological Productive capacity
infrastructure Venezuela Venezuela United States United States Thail and Thailand Poland Poland Philippines Philippines Mexico Mexico Malaysia Malaysia Japan Japan Israel Israel Ireland Ireland Indonesia Indonesia India India Hungary Hungary Germany Germany Czech Republic Czech Republic China China Brazil Brazil Argentina Argentina
0.0 20.0 40.0 60.0 80.0 100.0 0.0 20.0 40.0 60.0 80.0 100.0
Reference: Science and Engineering Indicators 2006 Gallasus Skin cell turned into stem cells;
Discovered by Professor Shinya Yamanaka, Kyoto University
Gallasus Science & Technology • Stem cell • Cellular and molecular biology • Nanotech • Material science
Academic & Research Institute • University of Tokyo • Kyyyoto University • Osaka University • Other universities • Government research institutes Gallasus 800
700 Japan Source; JETRO 600
500 s rr 400 German United y
300Numbe Kingdo m 200 Canada Netherl 110000 France ands
0
Gallasus AtAutomo tive 19% Others Electronics 25% 14%
Foods Drugs 9% 12%
Chemicals Manufactur 9% ing 12%
Source: Diamond Co. Ltd. “Corporate tax filing” Gallasus MbMembers
• Canon • TORAY • ThibToshiba • Mitsubishi Rayon Co. Ltd. • NGK Insulators, Ltd. • DNA Chip Institute • KAZUSA DNA Institute • Etc
Gallasus Fujitsu
Panasonic
Kirin acquired Kyowa Hakko.
Nintendo Honda; bio- Olympus; I n Vi vo fabric Imaging Gallasus Japan
1hr
1hr
Tokyo N2WldENo2 World Economy &I& Innovati on; All companies are within 1hr air flight reach.
Gallasus The company's primary business is coconsulting,nsulting, wwithith a focusfocus oonn evaluatingevaluating biotech companies and investment opportunities, finding partners for scientific collaboration and business alliances, an d ana lyz ing mar ke t an d business opportunities in the field of life sciences.
Gallasus Presented by CChikahika HashimotoHashimoto Gallasus, Inc. [email protected] +1(650)632-4341 +1(650)632-4599 Direc t 303 Twin Dolphin Dr. Suite 600 Redwood City CA 94065 USA
Gallasus